JP2018529345A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018529345A5 JP2018529345A5 JP2018515528A JP2018515528A JP2018529345A5 JP 2018529345 A5 JP2018529345 A5 JP 2018529345A5 JP 2018515528 A JP2018515528 A JP 2018515528A JP 2018515528 A JP2018515528 A JP 2018515528A JP 2018529345 A5 JP2018529345 A5 JP 2018529345A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- seq
- sample
- mammal
- cpg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 17
- 210000003719 b-lymphocyte Anatomy 0.000 claims 10
- 241000124008 Mammalia Species 0.000 claims 7
- 230000011987 methylation Effects 0.000 claims 7
- 238000007069 methylation reaction Methods 0.000 claims 7
- 239000000523 sample Substances 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 108091093088 Amplicon Proteins 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 5
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 4
- 238000004458 analytical method Methods 0.000 claims 4
- 238000012544 monitoring process Methods 0.000 claims 4
- 102000001770 Low Density Lipoprotein Receptor-Related Protein-5 Human genes 0.000 claims 3
- 108010015167 Low Density Lipoprotein Receptor-Related Protein-5 Proteins 0.000 claims 3
- 210000004369 blood Anatomy 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 210000002443 helper t lymphocyte Anatomy 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 108091029523 CpG island Proteins 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 108091036066 Three prime untranslated region Proteins 0.000 claims 1
- 108700009124 Transcription Initiation Site Proteins 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 239000012620 biological material Substances 0.000 claims 1
- 238000001369 bisulfite sequencing Methods 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000013068 control sample Substances 0.000 claims 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 1
- 230000017858 demethylation Effects 0.000 claims 1
- 238000010520 demethylation reaction Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000001976 enzyme digestion Methods 0.000 claims 1
- 230000003325 follicular Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims 1
- 210000003714 granulocyte Anatomy 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 210000001616 monocyte Anatomy 0.000 claims 1
- 210000000822 natural killer cell Anatomy 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 230000035897 transcription Effects 0.000 claims 1
- 238000013518 transcription Methods 0.000 claims 1
- 238000011144 upstream manufacturing Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1516972.5A GB201516972D0 (en) | 2015-09-25 | 2015-09-25 | LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells |
| GB1516972.5 | 2015-09-25 | ||
| PCT/EP2016/072579 WO2017050916A1 (en) | 2015-09-25 | 2016-09-22 | Lrp5 as epigenetic marker for the identification of immune cells, in particular b-cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018529345A JP2018529345A (ja) | 2018-10-11 |
| JP2018529345A5 true JP2018529345A5 (OSRAM) | 2019-10-31 |
Family
ID=54544102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018515528A Pending JP2018529345A (ja) | 2015-09-25 | 2016-09-22 | 免疫細胞、特にｂ細胞の同定のためのエピジェネティックマーカーとしてのｌｒｐ５ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11643687B2 (OSRAM) |
| EP (1) | EP3353318B1 (OSRAM) |
| JP (1) | JP2018529345A (OSRAM) |
| CN (1) | CN108026578A (OSRAM) |
| GB (1) | GB201516972D0 (OSRAM) |
| HK (1) | HK1257122A1 (OSRAM) |
| WO (1) | WO2017050916A1 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200340057A1 (en) * | 2017-07-13 | 2020-10-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Dna targets as tissue-specific methylation markers |
| CN111918964B (zh) * | 2018-03-26 | 2025-05-30 | 原启生物科技(上海)有限责任公司 | 促进免疫细胞增殖的方法 |
| DE102018112644B4 (de) * | 2018-05-25 | 2020-06-10 | Epiontis Gmbh | CXCR3 als epigenetischer Marker zur Identifizierung von inflammatorischen Immunzellen, insbesondere CD8+ Gedächnis-T-Zellen |
| DE102018116353B4 (de) * | 2018-07-05 | 2020-06-10 | Epiontis Gmbh | Verfahren zum Nachweis und zur Zählung epigenetischer Immunzellen in humanen Blutproben für Immundiagnostik und Neugeborenen-Screening |
| DE102020108560B4 (de) * | 2020-03-27 | 2022-03-03 | Precision For Medicine Gmbh | CBX6 als epigenetischer Marker für die Identifizierung von Immunzellen, insbesondere Gedächtnis-B-Zellen |
| CN119372296B (zh) * | 2024-12-24 | 2025-06-13 | 北京致谱医学检验实验室有限公司 | 基于基因甲基化检测实现人b淋巴细胞计数的试剂盒 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1285002B1 (en) * | 2000-05-26 | 2007-07-18 | Oscient Pharmaceuticals Corporation | Regulating lipid levels via the zmax1 or hbm gene |
| US20070243161A1 (en) * | 2006-02-28 | 2007-10-18 | Sven Olek | Epigenetic modification of the loci for CAMTA1 and/or FOXP3 as a marker for cancer treatment |
| SG185942A1 (en) * | 2007-11-02 | 2012-12-28 | Agency Science Tech & Res | Methods and compounds for preventing and treating a tumour |
| US20110104695A1 (en) * | 2009-11-05 | 2011-05-05 | Epigenomics Ag | Methods of predicting therapeutic efficacy of cancer therapy |
| JP6010037B2 (ja) * | 2010-10-08 | 2016-10-19 | エピオンティス ゲーエムベーハー | 腫瘍浸潤全ｔリンパ球の分析に基づいて、がん患者の生存指標を測定する方法 |
| WO2013033627A2 (en) * | 2011-09-01 | 2013-03-07 | The Regents Of The University Of California | Diagnosis and treatment of arthritis using epigenetics |
| PL3327141T3 (pl) * | 2013-04-19 | 2020-07-27 | Epiontis Gmbh | Sposób określania ilościowego składu komórkowego w próbce biologicznej |
| KR20170013921A (ko) | 2014-05-30 | 2017-02-07 | 로버트 필리버트 | 알콜 사용 및 금주에 대한 바이오마커로서의 ｄｎａ 메틸화 상태 |
-
2015
- 2015-09-25 GB GBGB1516972.5A patent/GB201516972D0/en not_active Ceased
-
2016
- 2016-09-22 JP JP2018515528A patent/JP2018529345A/ja active Pending
- 2016-09-22 US US15/752,072 patent/US11643687B2/en active Active
- 2016-09-22 EP EP16770025.1A patent/EP3353318B1/en active Active
- 2016-09-22 CN CN201680052685.1A patent/CN108026578A/zh active Pending
- 2016-09-22 WO PCT/EP2016/072579 patent/WO2017050916A1/en not_active Ceased
- 2016-09-22 HK HK18116376.0A patent/HK1257122A1/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jara-Acevedo et al. | Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications | |
| Houseman et al. | DNA methylation in whole blood: uses and challenges | |
| Agnelli et al. | Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma | |
| JP2012511917A5 (OSRAM) | ||
| EP3327141B1 (en) | Method for identifying the quantitative cellular composition in a biological sample | |
| JP2018529346A5 (OSRAM) | ||
| WO2007121276A3 (en) | Enrichment of circulating fetal dna | |
| JP2018534910A5 (OSRAM) | ||
| JP2022141905A (ja) | 移植拒絶リスクを予測する新規の方法 | |
| HK1257122A1 (zh) | Lrp5作为用於鉴定免疫细胞特别是b细胞的表观遗传标志物 | |
| Tomusiak et al. | Development of a novel epigenetic clock resistant to changes in immune cell composition | |
| Genshaft et al. | Clinical implementation of single-cell RNA sequencing using liver fine needle aspirate tissue sampling and centralized processing captures compartment specific immuno-diversity | |
| JP6113159B2 (ja) | ナチュラルキラー細胞を同定するエピジェネティックマーカー | |
| Brownlie et al. | Distinct lung-homing receptor expression and activation profiles on NK cell and T cell subsets in COVID-19 and influenza | |
| EP2625188A1 (en) | Molecular determinant-based typing of kir alleles and kir-ligands | |
| JP2021502806A5 (OSRAM) | ||
| CN105349641A (zh) | 急性心肌梗死相关基因serpinb13及其应用 | |
| CN111575375A (zh) | 一种多发性骨髓瘤基因突变检测试剂盒和检测方法 | |
| RU2715633C2 (ru) | Способ идентификации в иммунном репертуаре cdr3 участков, ассоциированных с заболеваниями | |
| JP2021502809A5 (OSRAM) | ||
| Amato et al. | Preferential usage of specific immunoglobulin heavy chain variable region genes with unmutated profile and advanced stage at presentation are common features in patients with chronic lymphocytic leukemia from Senegal | |
| Blanc et al. | Impact of a CD4 gene haplotype on the immune response in minipigs | |
| Nguyen et al. | A Composite Epigenetic Biomarker of FOXP3/TIGIT Correlates With Regulatory T Cell Numbers in Cord Blood and Is Associated With Subsequent Food Allergy | |
| WO2015052190A1 (en) | Predicting increased risk for cancer | |
| RU2706699C1 (ru) | Способ прогнозирования неблагоприятного течения фиброза печени при хроническом гепатите С |